Frequent Accesses to Totally Implanted Vascular Ports in Pediatric Oncology Patients are Associated with Higher Infection Rates

Purpose Totally implanted vascular (TIVA) ports are used in children for repeated blood samples or intravenous treatments. We have recently published a prospective evaluation of surgical incidents and early complications associated with these devices. This work is the final part of the same study, assessing late complications over a follow-up of 2 yrs. Methods From January 2006 to January 2008, children older than 1 yr of age with a diagnosis of solid or blood cell malignancy were included. Insertion technique and care of the device were standardized. Every manipulation was prospectively recorded by specialized nurses. Obstruction was documented clinically. When bacteremia was suspected, routine central and peripheral blood cultures were drawn. Results Forty-five consecutive patients were enrolled in the study. Mean age at the time of the procedure was 8.5 yrs. There was no catheter-related infection within the first 4 weeks post-surgery. No device had to be removed because of infection or obstruction during follow-up. Frequent accesses to the port (≥3 per day over a 10–day period) were associated with an 8–fold risk of infection. Conclusion Insertion and use of TIVA devices were frequently associated with complications. No device had to be removed because of infection or obstruction over the follow-up period, although no prophylactic antibiotic agent was used. Restrictive use of antibiotics may prevent opportunistic infection. Frequent access to the device was significantly associated with line infection (odds ratio=8.43). No risk factor was identified for obstruction which occurred at a rate of 5.3 per 10,000 accesses.

[1]  F. Cavalli,et al.  Randomised comparison of complications from three different permanent central venous access systems. , 2009, Swiss medical weekly.

[2]  S. Tercier,et al.  Incidents and complications of totally implanted vascular access devices in children: a prospective study , 2008, Patient safety in surgery.

[3]  A. Davidoff,et al.  Evaluation of pediatric oncology patients with previous multiple central catheters for vascular access: Is doppler ultrasound needed? , 2007, Pediatric blood & cancer.

[4]  C. Seiler,et al.  Surgical technique for totally implantable access ports (TIAP) needs improvement: A multivariate analysis of 400 patients , 2006, Journal of surgical oncology.

[5]  J. Kuhn,et al.  A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports. , 2004, American journal of surgery.

[6]  C. Benedetti,et al.  Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices , 2004, Supportive Care in Cancer.

[7]  A. Maubon,et al.  Thrombotic complications of implanted central venous access devices: prospective evaluation. , 2004, Bulletin du cancer.

[8]  C. Freytes Thromboembolic complications related to indwelling central venous catheters in children , 2003, Current opinion in oncology.

[9]  J. Tsai,et al.  Evaluation of infectious complications of the implantable venous access system in a general oncologic population. , 2003, American journal of infection control.

[10]  T. Wobbes,et al.  Single-centre experience with tunnelled central venous catheters in 150 cancer patients. , 2002, The Netherlands journal of medicine.

[11]  R. Spicer,et al.  Implanted vascular access devices (ports) in children: complications and their prevention , 2002, Pediatric Surgery International.

[12]  P. Monagle,et al.  Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study of 362 catheters , 2002, Supportive Care in Cancer.

[13]  A. Thomas,et al.  Totally implantable central venous access devices for paediatric oncology patients. , 1999, Medical and pediatric oncology.

[14]  E. Bow,et al.  Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  S. Ray,et al.  Epidemiology of Device-Associated Infections Related to a Long-Term Implantable Vascular Access Device , 1999, Infection Control & Hospital Epidemiology.